The Effect Of Methotrexate On Adalimumab Pharmacokinetics: Pooled Analysis Of Adalimumab Pharmacokinetics In Patients With Rheumatoid Arthritis After Subcutaneous Administration.

被引:0
|
作者
Awni, Walid [1 ]
Pilari, Sabine [2 ]
Ahmed, Ghada [1 ]
Noertersheuser, Peter [2 ]
机构
[1] AbbVie Inc, N Chicago, IL USA
[2] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
488
引用
收藏
页码:S214 / S214
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis
    Ternant, David
    Ducourau, Emilie
    Fuzibet, Piera
    Vignault, Celine
    Watier, Herve
    Lequerre, Thierry
    Le Loet, Xavier
    Vittecoq, Olivier
    Goupille, Philippe
    Mulleman, Denis
    Paintaud, Gilles
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (02) : 286 - 297
  • [2] Adalimumab pharmacokinetics and concentration-effect relationship in rheumatoid arthritis
    Ternant, D.
    Fuzibet, P.
    Ducourau, E.
    Vittecoq, O.
    Lequerre, T.
    Goupille, P.
    Mulleman, D.
    Paintaud, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 39 - 39
  • [3] Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial
    Goss, Sandra L.
    Klein, Cheri E.
    Jin, Ziyi
    Locke, Charles S.
    Rodila, Ramona C.
    Kupper, Hartmut
    Burmester, Gerd-Rudiger
    Awni, Walid M.
    CLINICAL THERAPEUTICS, 2018, 40 (02) : 309 - 319
  • [4] Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis
    Zhang, Xiaoping
    Chen, Ya-Chi
    Fettner, Scott
    Rowell, Lucy
    Gott, Tatiana
    Grimsey, Paul
    Unsworth, Adam
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (08) : 620 - 630
  • [5] THE EFFECT OF METHOTREXATE IN TREATMENT WITH ADALIMUMAB AND ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    l'Ami, M.
    Kneepkens, E.
    Krieckaert, C.
    Marsman, A.
    Ruwaard, J.
    Wolbink, G.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 708 - 709
  • [6] BODY WEIGHT AND SEX INFLUENCE THE PHARMACOKINETICS OF ADALIMUMAB IN RHEUMATOID ARTHRITIS
    Ducourau, E.
    Ternant, D.
    Lequerre, T.
    Fuzibet, P.
    Paintaud, G.
    Le Loet, X.
    Vittecoq, O.
    Goupille, P.
    Mulleman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 229 - 229
  • [7] Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate
    Rau, R
    Simianer, S
    van Riel, PLCM
    van de Putte, LBA
    Krüger, K
    Schattenkirchner, M
    Allaart, CF
    Breedveld, FC
    Kempeni, J
    Beck, K
    Kupper, H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (03) : 145 - 153
  • [8] Time lag between the initiation of adalimumab after methotrexate correlates with the efficacy of adalimumab in rheumatoid arthritis patients
    Kimura, Noriko
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2016, 26 (05) : 676 - 680
  • [9] Adalimumab and Methotrexate Pharmacokinetics Following Combination Therapy With Different Methotrexate Doses in Methotrexate and Biologic-Naive Rheumatoid Arthritis Patients: Concerto Study
    Goss, Sandra L.
    Klein, Cheri E.
    Kupper, Hartmut
    Burmester, Gerd R.
    Awni, Walid
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S212 - S212
  • [10] Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration
    Ahmed, Mansoor
    Luggen, Michael
    Herman, Jerome H.
    Weiss, Kenneth L.
    Decourten-Myers, Gabrielle
    Quinlan, John G.
    Khanna, Dinesh
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2344 - 2346